Provectus Biopharmaceuticals, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Provectus Biopharmaceuticals, Inc. (PVCT) is 0.06

According to Provectus Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.06. This represents a change of -7.99% compared to the average of 0.07 of the last 4 quarters.

Provectus Biopharmaceuticals, Inc. (PVCT) Historical Current Ratio (quarterly & annually)

How has PVCT Current Ratio performed in the past?

The mean historical Current Ratio of Provectus Biopharmaceuticals, Inc. over the last ten years is 0.27. The current 0.06 Current Ratio has changed 2.22% with respect to the historical average. Over the past ten years (40 quarters), PVCT's Current Ratio was at its highest in in the June 2016 quarter at 3.20. The Current Ratio was at its lowest in in the December 2020 quarter at 0.01.

Provectus Biopharmaceuticals, Inc. (PVCT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Provectus Biopharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Provectus Biopharmaceuticals, Inc. (PVCT) Average Current Ratio

How has PVCT Current Ratio performed in the past?

The current Current Ratio of Provectus Biopharmaceuticals, Inc. (PVCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Provectus Biopharmaceuticals, Inc. (PVCT) Current Ratio vs. Peers

How is PVCT’s Current Ratio compared to its peers?

Provectus Biopharmaceuticals, Inc.’s Current Ratio is less than Defence Therapeutics Inc. (3.37), less than Sernova Corp. (0.14), less than MedMira Inc. (0.07), less than Cynata Therapeutics Limited (2.49), less than Starpharma Holdings Limited (5.26), less than Bonus BioGroup Ltd. (0.21), less than WOWI, Inc. (0.72), less than Celyad Oncology S.A. (1.92), less than Microbix Biosystems Inc. (5.35), less than Next Science Limited (1.38),

Build a custom stock screener for Provectus Biopharmaceuticals, Inc. (PVCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Provectus Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Provectus Biopharmaceuticals, Inc. (PVCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Provectus Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.